Top 10 Diabetes Care Technologies, Devices and Global Therapeutics Neurodegenerative Markets Market -Diseases Growth, Global Share, Industry Overview, Analysis, 2015-2019 Trends Opportunities and Forecast 2012 - 2020
Report Overview Description
About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington’s disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer’s disease and Parkinson’s disease which have a high degree of prevalence. Global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/globalneurodegenerative-diseases-2015-2019-market @Bigmarketresearch
Key Benefits
Description This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of: • Alzheimer's Disease • Parkinson's Disease • Multiple Sclerosis • Epilepsy • Huntington's Disease • Amyotrophic Lateral Sclerosis
@Bigmarketresearch
Description The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of neurodegenerative diseases are discussed. Global Neurodegenerative Diseases Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC; it also covers the global neurodegenerative diseases market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA @Bigmarketresearch
Description Key vendors • Biogen Idec • Merck Serono • Novartis • Pfizer • Teva Pharmaceutical Industries • UCB Other Prominent Vendors • AB Science • Abbvie • Acorda Therapeutics • Actavis • Active Biotech • Adamas Pharmaceuticals • Akorn • Archer Pharmaceuticals • Astellas @Bigmarketresearch
Table Of Contents
Table Of Content
01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Product Profiles 05. Market Research Methodology 05.1 Market Research Process 05.2 Research Methodology 06. Introduction 07. Market Landscape 08. Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 09. Global Multiple Sclerosis Market 10. Global Alzheimer's Disease Market
Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/222191
@Bigmarketresearch
Get Full Information At: http://www.bigmarketresearch.com /global-neurodegenerativediseases-2015-2019-market